Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization against HCG

P D Griffin1

  • 1Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

Human Reproduction (Oxford, England)
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunocontraceptives.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Effects of levonorgestrel butanoate alone and in combination with testosterone buciclate on spermatogenesis in the bonnet monkey.

Andrologia·2007
Same author

Evaluation of the ability of levonorgestrel butanoate alone, or in combination with testosterone buciclate, to suppress spermatogenesis in the bonnet monkey (Macaca radiata).

International journal of andrology·2000
Same author

Pushing the frontiers of science--the WHO/Rockefeller Foundation Initiative on implantation.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2000
Same author

Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug.

International journal of andrology·1998
Same author

A male contraceptive pill.

Nature medicine·1996
Same journal

ESHRE recommendations on Good Practice in the IVF laboratory†.

Human reproduction (Oxford, England)·2026
Same journal

Evidence for de novo synthesis of corticosteroids in the human ovary.

Human reproduction (Oxford, England)·2026
Same journal

Characterizing endometriosis and adenomyosis symptom clusters and their impact on quality of life in the All of Us Research Program.

Human reproduction (Oxford, England)·2026
Same journal

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

Human reproduction (Oxford, England)·2026
Same journal

Subfertility in relation to gestational weight gain and gestational diabetes: the Norwegian Mother, Father and Child Cohort Study.

Human reproduction (Oxford, England)·2026
Same journal

Pathogenic variants in ACTRT3 lead to male infertility characterized by fertilization defects.

Human reproduction (Oxford, England)·2026
See all related articles

Birth control vaccines targeting human chorionic gonadotrophin (HCG) are in clinical trials. These safe and effective vaccines offer a new family planning method for men and women.

Area of Science:

  • Immunology
  • Reproductive Health
  • Vaccinology

Background:

  • The concept of immunological contraception has existed since early immunology.
  • Significant research over decades aims to develop safe and effective birth control vaccines for all reproductive ages.
  • Current advanced research focuses on vaccines targeting human chorionic gonadotrophin (HCG).

Purpose of the Study:

  • To develop and clinically test birth control vaccines for men and women.
  • To create a novel family planning method utilizing the immune system.
  • To advance vaccine development against HCG for effective contraception.

Main Methods:

  • Development of prototype vaccines targeting different parts of the HCG molecule.
  • Clinical testing of HCG-based vaccines.
Keywords:
BiologyContraceptionContraception ResearchContraception, ImmunologicalEndocrine SystemFamily PlanningGonadotropinsGonadotropins, ChorionicHormonesPhysiology

Related Experiment Videos

  • Research into improved vaccine formulations for extended protection.

    • Main Results:

    • Prototype HCG vaccines have reached the clinical testing phase.
    • No adverse side effects have been reported in clinical trials to date.
    • Larger scale studies are planned to further evaluate safety and efficacy.

    Conclusions:

    • HCG vaccines represent a promising new avenue for family planning.
    • The development of these vaccines is nearing the introduction phase.
    • Immunological contraception offers a potentially revolutionary family planning method.